Cognition Therapeutics (CGTX) Other Working Capital Changes (2020 - 2026)
Cognition Therapeutics (CGTX) posted quarterly Other Working Capital Changes of -$60000.0 for Q1 2026, up 1.64% year-over-year from -$59032.3 in Q1 2025, and down 22.45% quarter-over-quarter from -$49000.0 in Q4 2025.
Cognition Therapeutics (CGTX) Other Working Capital Changes (2020 - 2026) Analysis & Trends
Cognition Therapeutics (CGTX) has reported Other Working Capital Changes for 5 consecutive years, with -$60000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Working Capital Changes rose 1.64% year-over-year to -$60000.0; the TTM figure through Mar 2026 stood at -$203000.0 (down 4.64% YoY), while the FY2025 annual figure was -$204000.0, down 28.3% from the prior year.
- Other Working Capital Changes fell to -$60000.0 in Q1 2026 per CGTX's latest filing, from -$49000.0 in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $1.1 million in Q1 2022 and bottomed at -$890000.0 in Q4 2023.
- Historically, Other Working Capital Changes has averaged -$205411.8 across 5 years, with a median of -$210000.0 in 2023.
- Annual changes were most pronounced in 2024 — Other Working Capital Changes gained 27.78% — and 2025, when it slumped 134.62%.
- Cognition Therapeutics' Other Working Capital Changes stood at -$33000.0 in 2022, then decreased by 24.24% to -$41000.0 in 2023, then fell by 9.76% to -$45000.0 in 2024, then fell by 8.89% to -$49000.0 in 2025, then fell by 22.45% to -$60000.0 in 2026.
- Business Quant data shows CGTX's Other Working Capital Changes at -$60000.0 in Q1 2026, -$49000.0 in Q4 2025, and -$47000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.95 Bn | 132.10 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.71 Bn | 78.72 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.71 Bn | 60.52 Bn | 1.37 Bn |
| 4 | Moderna | 60.45 Bn | 55.31 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.24 Bn | 37.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.80 Bn | 28.49 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.64 Bn | 10.25 Bn | 668.28 Mn |
| 8 | Insmed | 27.61 Bn | 26.45 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.26 Bn | 26.42 Bn | - |
| 10 | Cognition Therapeutics | 90.16 Mn | 90.16 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -346,000.00 |
| Jun 30, 2026 | -346,000.00 |
| Jun 30, 2026 | -346,000.00 |
| Mar 31, 2026 | -136,000.00 |
| Mar 31, 2026 | -136,000.00 |
| Mar 31, 2026 | -136,000.00 |
| Dec 31, 2025 | -473,000.00 |
| Dec 31, 2025 | -473,000.00 |
| Dec 31, 2025 | -473,000.00 |
| Sep 30, 2025 | -47,000.00 |
| Sep 30, 2025 | -47,000.00 |
| Sep 30, 2025 | -47,000.00 |
| Jun 30, 2025 | -453,000.00 |
| Jun 30, 2025 | -453,000.00 |
| Jun 30, 2025 | -453,000.00 |
| Mar 31, 2025 | -200,000.00 |
| Mar 31, 2025 | -200,000.00 |
| Mar 31, 2025 | -200,000.00 |
| Dec 31, 2024 | -64,000.00 |
| Dec 31, 2024 | -64,000.00 |